HISTORY

OUR NEVER-ENDING COMMITMENT TO LEVITATE OUR CORPORATE STANCE IN THE GLOBAL MARKETLEAVES BEHIND A COLORFUL AND EXCITING GROWTH STORY

THE YEARS OF RESEARCH BEHIND TESSLIFT'S TECHNOLOGY HAVE UPGRADED ITS BRAND PORTFOLIO AND &D AFFAIRS

FOUNDATION OF

TESSLIFT

2007. 03.

Collaborations among biomedical engineers and surgeons have established R&D of an implant for tissue suspention.

2008. 08.

Company name "Jimmy Kim Corp." has changed to "TESSLIFT Co., Ltd." (former CEO. Jimmy Kim, the bio-medical engineer).

2012. 06.

Patent PCT International Application for "Graft for Tissue Lifting" 9PCT/KR2012/004421)

2012. 06.

Patent Registration for "Graft for Tissue Lifting"

2012. 07.

Established the OEM Agreement for registered TESSLIFT products.

2012. 08.

Appointed Dr. Min Kim, MD, as the CEO and Medical Advi-sory Board Chair of TESSLIFT Co., Ltd. to foster the R&D for TESSLIFT's products portfolio.

2012. 08.

Business Agreement for TESSLIFT's products with Hugel Pharma, subsidiary of Hugel, Inc.

2012. 09.

Showcased at the 4th International Congress of Minimally Invasive Plastic Surgery.

2012. 10.

Live demonstration lecture for TESSLIFT products at the 25th Congress of Korean Society of Aesthetic Sugery.

2013. 04.

International trademarks registrations for Madrid (Associat-ed countries: Australia, China, EU, Japen, Russia, USA)

EXPANSION OF

TESSLIFT

2013. 04.

Live demonstration lecure for TESSLIFT's products at the 26th Congress of Korean Society of Aestheic Surgery.

2013. 07.

Established the firs plant and gead office at Wonju Medical Industry Techno Valley.

2013. 09.

Registered for manufacturing business for medical devices.

2014. 03.

Showcased at the Asia Forum for Aestheic Surgery & Med-icine.

2014. 04.

Showcased at the 2nd Congress of Asia Anti-Aging & Re-generative Medicine.

2014. 04.

Showcased at the 11th Congress of Eastern Cosmetic Surgery.

2014. 05.

Entitled to KGMP certification on Wonju plant.

2014. 06.

Registered 2-dimensional non-absorbable TESSLIFT-010 product by Ministry of Food and Drug Safety.

2015. 01.

Registered 2-dimensional non-absorbable TESSLIFT-020 and TL-010 delivery devices products by Ministry of Food and Drug Safety.

GLOBAL FOOTAGE OF

TESSLIFT

2016. 06.

Registered 3-dimensional non-absorbable TESSLIFT-160 and U Lift-060 products by Ministry Food and Drug Safety.

2016. 08.

Invited to speak at EAM, Indonesia Aesthetic Medicine.

2016. 09.

Registered absorbable V Lift products by Ministry of Food and Drug Safety.

2016. 09.

Business Agreement for U Lift-060 and V lift products with DN Company, subsidiary of Daewoong Pharm.

2016. 10.

Showcased at the 2016 International Congress of Ko-rea-Japen-China Aesthetic Surgery & Medicine.

2016. 11.

Showcased at the 33rd The Congress of Korean Society of Aesthetic Surgery.

2016. 11.

Established the Corporate R&D Center for implant for tissue suspension.

2016. 12.

Corporate R&D Center Accreditation by Korea Industrial Technology Association (KOITA).

2017. 02.

Entitled to ISO 13485 certification (TUV SUD, Germany) for Wonju plant.

2017. 02.

Initial Partner Agreement with Samsung Seoul Hospital for Government R&D project

2017. 02.

Registered absorbable TESSLIFT SOFT products by Min-istry of Food and Drug Safety

2017. 02.

Patent registration for "Device for Tissue Suspension and Fixation"

2017. 03.

Appointed Hee Jang, BL as the CEO of TESSLIFT Co., Ltd. for his expertise in trading and laws.

2017. 04.

Showcased at he 15th Aesthetic & Anti-aging Medicine, AMWC.

OUR BRANDS

  • Instagram - Grey Circle
  • Facebook - Grey Circle
  • Twitter - Grey Circle
  • LinkedIn - Grey Circle

The group companies of 

©COPYRIGHT 2019 TESSLIFT 

group.png